Key players include Novo Nordisk, Eli Lilly, Sanofi, Boehringer Ingelheim, AstraZeneca, Amgen, Merck & Co., and Bristol-Myers Squibb
2015;314(7):687 Large weight loss trial with liraglutide that demonstrates BP (clinic BP) lowering with liraglutide administration
Also, rising incidence of metabolic disorders also drive the regional market expansion
Others may need it long-term, similar to how people with hypertension or high cholesterol may need ongoing treatment
Expression of the GHS-R1a mRNA is found in several nuclei of the hypothalamus, hippocampus, substantia nigra, ventral tegmental area (VTA), dorsal and median raphe nuclei, anterior pituitary gland, pancreatic islets, adrenal gland, thyroid, lung, liver, kidney, immune cells, intestine, adipose tissue, and myocardium